Literature DB >> 2886149

pH-dependent bilayer destabilization by an amphipathic peptide.

N K Subbarao, R A Parente, F C Szoka, L Nadasdi, K Pongracz.   

Abstract

A 30-residue amphipathic peptide was designed to interact with uncharged bilayers in a pH-dependent fashion. This was achieved by a pH-induced random coil-alpha-helical transition, exposing a hydrophobic face in the peptide. The repeat unit of the peptide, glutamic acid-alanine-leucine-alanine (GALA), positioned glutamic acid residues on the same face of the helix, and at pH 7.5, charge repulsion between aligned Glu destabilized the helix. A tryptophan was included at the N-terminal as a fluorescence probe. The rate and extent of peptide-induced leakage of contents from large, unilamellar vesicles composed of egg phosphatidylcholine were dependent on pH. At pH 5.0 with a lipid/peptide mole ratio of 500/1, 100% leakage of vesicle contents occurred within 1 min. However, no leakage of vesicle contents occurred at pH 7.5. Circular dichroism measurements indicated that the molar ellipticity at 222 nm changed from about -4000 deg cm2 dmol-1 at pH 7.6 to -11,500 deg cm2 dmol-1 at pH 5.1, indicating a substantial increase in helical content as the pH was reduced. Changes in molar ellipticity were most significant over the same pH range where a maximum change in the extent and rate of leakage occurred. The tryptophan fluorescence emission spectra and the circular dichroism spectra of the peptide, in the presence of lipid, suggest that GALA did not associate with the bilayer at neutral pH. A change in the circular dichroism spectrum and a blue shift of the maximum of the tryptophan fluorescence emission spectra at pH 5.0, in the presence of lipid, indicated an association of GALA with the bilayer.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2886149     DOI: 10.1021/bi00385a002

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  49 in total

1.  Orientation of the pore-forming peptide GALA in POPC vesicles determined by a BODIPY-avidin/biotin binding assay.

Authors:  F Nicol; S Nir; F C Szoka
Journal:  Biophys J       Date:  1999-04       Impact factor: 4.033

2.  Reactive and bioactive cationic α-helical polypeptide template for nonviral gene delivery.

Authors:  Nathan P Gabrielson; Hua Lu; Lichen Yin; Dong Li; Fei Wang; Jianjun Cheng
Journal:  Angew Chem Int Ed Engl       Date:  2011-12-07       Impact factor: 15.336

3.  Effect of phospholipid composition on an amphipathic peptide-mediated pore formation in bilayer vesicles.

Authors:  F Nicol; S Nir; F C Szoka
Journal:  Biophys J       Date:  2000-02       Impact factor: 4.033

Review 4.  Silk-based delivery systems of bioactive molecules.

Authors:  Keiji Numata; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2010-03-16       Impact factor: 15.470

Review 5.  Peptide-guided gene delivery.

Authors:  Molly E Martin; Kevin G Rice
Journal:  AAPS J       Date:  2007-02-09       Impact factor: 4.009

Review 6.  Exploiting endocytosis for nanomedicines.

Authors:  Akin Akinc; Giuseppe Battaglia
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-11-01       Impact factor: 10.005

7.  A truncated HGP peptide sequence that retains endosomolytic activity and improves gene delivery efficiencies.

Authors:  Ester J Kwon; Sylvie Liong; Suzie H Pun
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

8.  A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy.

Authors:  J G Duguid; C Li; M Shi; M J Logan; H Alila; A Rolland; E Tomlinson; J T Sparrow; L C Smith
Journal:  Biophys J       Date:  1998-06       Impact factor: 4.033

9.  Steroidogenic activity of a peptide specified by the reversed sequence of corticotropin mRNA.

Authors:  B L Clarke; J E Blalock
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 10.  Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.

Authors:  Srinivas Ramishetti; Leaf Huang
Journal:  Ther Deliv       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.